A life ensnarled in gangs, drugs, dreams of prison, until counselor steps in

A life ensnarled in gangs, drugs, dreams of prison, until counselor steps in
Y.E.S. is one of the agencies benefiting from The Seattle Times Fund for The Needy. Each year, the center helps about 35,000 children and families in East King County make their way through drug and alcohol abuse, sexual abuse, depression and violence.
Read more on Seattle Times

FDA approves Abiomed to begin MINI-AMI trial to evaluate Impella 2.5
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
Read more on News-Medical-Net

FDA Advisory Panel recommends approval of Solesta for bowel incontinence
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration’s (FDA) Gastroenterology and Urology Devices Panel recommended approval of Solesta™ as a treatment for fecal (bowel) incontinence, a condition afflicting many Americans, primarily women.
Read more on News-Medical-Net